CHARLOTTE, N.C., Sept. 06, 2017 -- Encompass Compliance Corp. (OTCPINK:ENCC) signs an agreement with National Association of Professional Background Screeners (NAPBS), allowing its members access to ENCC’s “Risk Shield” and “Resource Center” knowledge compliance services.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/bf97551a-5ea3-42a1-87e2-6227cbb59ee2.
“We are very excited about our newest affinity program with Encompass Compliance Corporation,” says NAPBS Executive Director Melissa Sorenson. “NAPBS members tremendously benefit when we can offer industry-specific programs such as this one to our members, helping to improve our members’ overall business at a reduced cost.”
The “Risk Shield” offering allows NAPBS to provide unrivaled technology that generates up-to-date drug and alcohol policies and procedures and alert users when changes occur, in any state.
“NAPBS and their members have a razor focus on providing the best solutions to their members and those members to their respective customers. Also, members have access to our ‘Resource Center’ which provides well organized and specific detail on all aspects of drug and alcohol compliance in all states,” says Encompass CEO Richard Sharp.
About NAPBS
Founded as a non-profit trade association in 2003, the National Association of Professional Background Screeners (NAPBS) established itself to represent the interest of companies offering employment and tenant background screening services. The Association currently represents over 880 member companies engaged in employment and tenant background screening across the United States. Member companies range from Fortune 100 companies to small local businesses, conducting millions of employment-related and tenant background checks each year as part of the hiring and leasing process. NAPBS Member companies are defined as “consumer reporting agencies” under the Fair Credit Reporting Act (FCRA), regulated by both the FTC and CFPB.
About Encompass Compliance Corp.
Encompass Compliance Corp. (OTCPINK:ENCC) provides the most comprehensive workplace drug and alcohol testing compliance services, with over 30 years of experience. ENCC with its dedication to providing employers the tools necessary to mitigate regulatory and compliance risk by complying with Workers Compensation laws, OSHA, ADA, Marijuana both personal and medical use, and much more. ENNC’s solutions provide organizations with up-to-date policies, a comprehensive resource center and real-time monitoring for drug & alcohol testing orders to assist users with the ability to confirm if a testing scenario is compliant with state regulations.
For further information, contact Richard Sharp at 866-328-7487 or [email protected] and https://www.encompinc.com/.
Safe Harbor Statement:
This press release may include predictions, estimates, opinions or statements that might be considered "forward-looking" under the provisions of the Private Securities Litigation Reform Act of 1995. Statements identified by phrases such as the Company or its management "believes," "expects," "forecasts," "estimates," or other words or phrases are forward-looking.
Contact Richard Sharp Encompass Compliance Corp. 866-328-7487 [email protected]


SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Bank of America's $72.5M Epstein Settlement: What You Need to Know
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Apple Turns 50: From Garage Startup to AI Crossroads
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears 



